[News] Morphine manifesto seeks to boost access to oral morphine

January, 01, 2024 | Select Oncology Journal Articles

A group of global, regional, and national palliative care organisations has urged governments and regulators to take steps to end the practice of pharmaceutical companies marketing sustained-release morphine and expensive opioid formulations, and to ensure the availability of generic immediate-release oral morphine for pain management.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy